For determining these heterogeneities, we designed a systematic study and meta-analysis according to the previous results, in order to achieve a more precise estimation of the correlation between the genes involved in the IGF pathway (IGF1, IGF1R, IRS1, and IRS2) and the risk of CRC for the first time. This evidence concerns the gene IRS2 and colorectal carcinoma.